Information Provided By:
Fly News Breaks for April 26, 2019
Apr 26, 2019 | 05:05 EDT
Goldman Sachs analyst Paul Choi upgraded The Medicines Co. to Buy from Neutral and raised his price target for the shares to $55 from $25 ahead of the company's Phase III data in Q3.
News For MDCO From the Last 2 Days
There are no results for your query MDCO